Clinical Phenotypes of Patients with Anti-Dfs70/Ledgf Antibodies in A Routine ANA Referral Cohort

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Miyara, Makoto ^a   Albesa, Roger ^b   Charuel, Jean Luc ^a   El Amri, Mohamed ^a   Fritzler, Marvin J ^c   Ghillani Dalbin, Pascale ^a   Amoura, Zahir ^a   Musset, Lucile ^a   Mahler, Michael ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INOVA DIAGNOSTICS INC   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; LENS EPITHELIUM DERIVED GROWTH FACTOR; LENS EPITHELIUM DERIVED GROWTH FACTOR ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY; PSIP1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR;

ALGORITHM; ARTICLE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RHEUMATIC DISEASE; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; AUTOIMMUNE DISEASE; BLOOD; COHORT ANALYSIS; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; LUMINESCENCE; METHODOLOGY; PREDICTIVE VALUE; SEROLOGY; STATISTICS; TERTIARY HEALTH CARE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALGORITHMS; ANTIBODIES; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; COHORT STUDIES; DIAGNOSTIC TESTS, ROUTINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LUMINESCENT MEASUREMENTS; PREDICTIVE VALUE OF TESTS; RHEUMATIC DISEASES; SEROLOGIC TESTS; TERTIARY CARE CENTERS; TRANSCRIPTION FACTORS;

MLCS; MLOWN;

EID: 84874551075     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/703759     Document Type: Article

References (38)

1. Mahler M., Fritzler M. J., Epitope specificity and significance in systemic autoimmune diseases. Annals of the New York Academy of Sciences 2010 1183 267 287 2-s2.0-75749123045 10.1111/j.1749-6632.2009.05127.x
2. Meroni P. L., Schur P. H., ANA screening: an old test with new recommendations. Annals of the Rheumatic Diseases 2010 69 8 1420 1422 2-s2.0-77955462255 10.1136/ard.2009.127100
3. Ochs R. L., Muro Y., Si Y., Ge H., Chan E. K. L., Tan E. M., Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. The Journal of Allergy and Clinical Immunology 2000 105 6, part 1 1211 1220 2-s2.0-0033916267 10.1067/mai.2000.107039 (Pubitemid 30418802)
4. Ganapathy V., Casiano C. A., Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying to tell Us? Arthritis & Rheumatism 2004 50 3 684 688 2-s2.0-1542373697 10.1002/art.20095 (Pubitemid 38326165)
5. Ochs R. L., Stein T. W. Jr., Peebles C. L., Gittes R. F., Tan E. M., Autoantibodies in interstitial cystitis. Journal of Urology 1994 151 3 587 592 2-s2.0-0028069584 (Pubitemid 24054690)
6. Shinohara T., Singh D. P., Chylack L. T. Jr., Review: age-related cataract: immunity and lens epithelium-derived growth factor (LEDGF). Journal of Ocular Pharmacology and Therapeutics 2000 16 2 181 191 2-s2.0-0034093613 (Pubitemid 30235977)
7. Daniels T., Zhang J., Gutierrez I., Elliot M. L., Yamada B., Heeb M. J., Sheets S. M., Wu X., Casiano C. A., Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis. Prostate 2005 62 1 14 26 2-s2.0-10144237224 10.1002/pros.20112 (Pubitemid 39614289)
8. Maertens G., Cherepanov P., Pluymers W., Busschots K., De Clercq E., Debyser Z., Engelborghs Y., LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. The Journal of Biological Chemistry 2003 278 35 33528 33539 2-s2.0-0041856142 10.1074/jbc.M303594200 (Pubitemid 37055807)
9. Watanabe A., Kodera M., Sugiura K., Usuda T., Tan E. M., Takasaki Y., Tomita Y., Muro Y., Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis & Rheumatism 2004 50 3 892 900 2-s2.0-1542283747 10.1002/art.20096 (Pubitemid 38326190)
10. Dellavance A., Viana V. S. T., Leon E. P., Bonfa E. S. D. O., Andrade L. E. C., Leser P. G., The clinical spectrum of antinuclear antibodies associated with the nuclear dense fine speckled immunofluorescence pattern. The Journal of Rheumatology 2005 32 11 2144 2149 2-s2.0-27744503937 (Pubitemid 41587858)
11. Yamada K., Senju S., Shinohara T., Nakatsura T., Murata Y., Ishihara M., Nakamura S., Ohno S., Negi A., Nishimura Y., Humoral immune response directed against LEDGF in patients with VKH. Immunology Letters 2001 78 3 161 168 2-s2.0-0035478339 10.1016/S0165-2478(01)00243-7 (Pubitemid 32905388)
12. Ayaki M., Ohoguro N., Azuma N., Majima Y., Yata K., Ibaraki N., Singh D. P., Ko V., Shinohara T., Detection of cytotoxic anti-LEDGF autoantibodies in atopic dermatitis. Autoimmunity 2002 35 5 319 327 2-s2.0-0036700503 10.1080/0891693021000003198 (Pubitemid 35189674)
13. Mariz H. A., Sato E. I., Barbosa S. H., Rodrigues S. H., Dellavance A., Andrade L. E., Ana HEp-2 pattern is a critical parameter for discriminating ana-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis & Rheumatism 2011 63 1 191 200
14. Muro Y., Sugiura K., Morita Y., Tomita Y., High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease. Lupus 2008 17 3 171 176 2-s2.0-42549142948 10.1177/0961203307086311 (Pubitemid 351588938)
15. Mahler M., Hanlyand J. G., Fritzler M. J., Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases. Autoimmunity Reviews 2011 11 9 642 645 10.1016/j.autrev.2011.11.005
16. Tan E. M., Cohen A. S., Fries J. F., The 1982 revised criteria for the classification of systemic lupus erythrematosus. Arthritis & Rheumatism 1982 25 11 1271 1277 2-s2.0-0020436689 (Pubitemid 13221242)
17. Johnson S. R., Fransen J., Khanna D., Validation of potential classification criteria for systemic sclerosis. Arthritis Care & Research 2012 64 3 358 367 10.1002/acr.20684
18. Narain S., Richards H. B., Satoh M., Sarmiento M., Davidson R., Shuster J., Sobel E., Hahn P., Reeves W. H., Diagnostic accuracy for lupus and other systemic autoimmune diseases in the community setting. Archives of Internal Medicine 2004 164 22 2435 2441 2-s2.0-10344222129 10.1001/archinte.164.22.2435 (Pubitemid 39628070)
19. Arbuckle M. R., McClain M. T., Rubertone M. V., Hal Scofield R., Dennis G. J., James J. A., Harley J. B., Development of autoantibodies before the clinical onset of systemic lupus erythematosus. The New England Journal of Medicine 2003 349 16 1526 1533 2-s2.0-0142009533 10.1056/NEJMoa021933 (Pubitemid 37255038)
20. Eriksson C., Kokkonen H., Johansson M., Hallmans G., Wadelland G., Rantapaa-Dahlqvist S., Autoantibodies predate the onset of systemic lupus erythematosus in Northern Sweden. Arthritis Research & Therapy 2011 13 1, article R30 10.1186/ar3258
21. Fritzler M. J., The antinuclear antibody test: last or lasting gasp? Arthritis & Rheumatism 2011 63 1 19 22 2-s2.0-78650796222 10.1002/art.30078
22. Mahler M., Fritzler M. J., Blüthner M., Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies. Arthritis Research & Therapy 2005 7 1 R19 R29 2-s2.0-12544255536
23. Mahler M., Parker T., Peebles C. L., Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases. The Journal of Rheumatology 2012 39 11 2104 2110
24. Mahler M., Radice A., Sinico R. A., Performance evaluation of a novel chemiluminescence assay for detection of anti-GBM antibodies: an international multicenter study. Nephrology Dialysis Transplantation 2011 27 1 243 252
25. Mahler M., Radice A., Yang W., Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies. Clinica Chimica Acta 2012 413 7-8 719 726 10.1016/j.cca.2012.01.004
26. Copple S. S., Sawitzke A. D., Wilson A. M., Tebo A. E., Hill H. R., Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies: a statistical analysis. American Journal of Clinical Pathology 2011 135 5 678 684 2-s2.0-79955016785 10.1309/AJCP6R8EELGODAYW
27. Fenger M., Wiik A., Høier-Madsen M., Lykkegaard J. J., Rozenfeld T., Hansen M. S., Samsoe B. D., Jacobsen So. S. Ø., Detection of antinuclear antibodies by solid-phase immunoassays and immunofluorescence analysis. Clinical Chemistry 2004 50 11 2141 2147 2-s2.0-7044241196 10.1373/clinchem.2004.038422 (Pubitemid 39425853)
28. Fijorek K., Fijorek D., Wisniowska B., Polak S., BDTcomparator: a program for comparing binary classifiers. Bioinformatics 2011 27 24 3439 3440 10.1093/bioinformatics/btr574
29. Nofuentes J. A. R., del Castillo J. D. D. L., Comparison of the likelihood ratios of two binary diagnostic tests in paired designs. Statistics in Medicine 2007 26 22 4179 4201 2-s2.0-34548636469 10.1002/sim.2850 (Pubitemid 47399347)
30. 4 autoantibodies against DFS70/LEDGF in atopic dermatitis. Autoimmunity 2011 44 6 511 519 10.3109/08916934.2010.549157
31. Ogawa Y., Sugiura K., Watanabe A., Kunimatsu M., Mishima M., Tomita Y., Muro Y., Autoantigenicity of DFS70 is restricted to the conformational epitope of C-terminal alpha-helical domain. Journal of Autoimmunity 2004 23 3 221 231 2-s2.0-14244257153 10.1016/j.jaut.2004.07.003 (Pubitemid 40288104)
32. Shoenfeld Y., Toubi E., Protective autoantibodies: role in homeostasis, clinical importance, and therapeutic potential. Arthritis & Rheumatism 2005 52 9 2599 2606 2-s2.0-25444485683 10.1002/art.21252 (Pubitemid 41369087)
33. Fritzler M. J., Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferent. Autoimmunity Highlights 2012 3 2 51 58
34. Bizzaro N., Tonutti E., Visentini D., Alessio M. G., Platzgummer S., Morozzi G., Antico A., Villalta D., Piller-Roner S., Vigevani E., Antibodies to the lens and cornea in anti-DFS70-positive subjects. Annals of the New York Academy of Sciences 2007 1107 174 183 2-s2.0-34648840849 10.1196/annals.1381.019 (Pubitemid 47528794)
35. Mahler M., Ngo J. T., Schulte-Pelkum J., Luettich T., Fritzler M. J., Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodies. Arthritis Research and Therapy 2008 10 6, article R131 2-s2.0-57049084479 10.1186/ar2548
36. Mahler M., Silverman E. D., Fritzler M. J., Novel diagnostic and clinical aspects of anti-PCNA antibodies detected by novel detection methods. Lupus 2010 19 13 1527 1533 2-s2.0-78649279390 10.1177/0961203310375265
37. Bizzaro N., Tonutti E., Villalta D., Recognizing the dense fine speckled/lens epithelium-derived growth factor/p75 pattern on HEP-2 cells: not an easy task! Comment on the article by Mariz et al. Arthritis & Rheumatism 2011 63 12 4036 4037 10.1002/art.30621
38. Craig W. Y., Ledue T. B., The dense fine speckled antinuclear antibody pattern in autoimmune rheumatic disease: comment on the article by Mariz et al. Arthritis & Rheumatism 2011 63 6 1759 2-s2.0-79958076673 10.1002/art.30347